In our webinar, "Medical, reimagined: How technology-driven insights can help us rethink strategy and execution," we engaged with participants to explore their perspectives on the technology advancements in healthcare. We delved into the challenges they encounter while integrating new technologies into medical affairs to create a more efficient, effective, and inspiring scientific future for pharma. Discover our report and contact us for the webinar recording 👉 [email protected].
Envision Pharma Group’s Post
More Relevant Posts
-
Interested in learning about the latest clinical findings shaping patient care, pharma and finance? Tune into this Oracle-hosted webinar featuring experts from across the life sciences industry. https://lnkd.in/d5Xhgwyi
To view or add a comment, sign in
-
Have you already signed up for our free 4C Close-up webinar! 😀 Topic: C3-Clinical Studies | How to certify a large language model as a medical device?
How to certify an #AI-based product as a medical device? Sign up for our next #4CCloseUp webinar on July 30, 2024, where we will discuss the topics of validation, clinical evaluation, and certification process in the context of a #LargeLanguageModel. 🗨 Meet our speakers! Dr. Vera Roedel is Co-Founder and CEO of Prof. Valmed® - validated medical information GmbH. As a lawyer holding a Master in Health and Medical Management she is active in the pharmaceutical industry and the healthcare sector for several years. This wealth of experience allows her, along with her Co-Founder Heinz Wiendl, to pinpoint the needs of healthcare professionals endorsing Prof. Valmed‘s® vision. Dr. Henrike Stutzki is Consultant & Expert for C3-Clinical Studies at our team. She has many years of experience in coordinating clinical trials for medical devices but also brings a scientific background in biology and neuroscience. In addition to MII, she works as Head of Clinical Affairs at the MedTech startup sync2brain GmbH. Her practical experience from previous positions as well as from her current role in a startup add great value to her coaching and consulting of our clients. Sign up here for #free 👉 https://lnkd.in/ekSF9sbX
To view or add a comment, sign in
-
CEO, Avira Digital, Advancing patient care with Integrated Evidence & Medical Affairs Planning Digitization and GenAI
In this week's episode of Redefining Evidence Management, we have Samm Zombolo, Senior Vice President of Medical Affairs and HEOR at EPM Scientific, discussing her unique journey into medical affairs. Samm shares her insights on the transformative impact of digital advancements and AI on the pharmaceutical and biotech industries. Discover how integrating technology is reshaping medical affairs and the importance of adaptability in this fast-evolving field. Join us as Samm explores the future of medical affairs, the integration of strategic development, and the role of patient-centric approaches in modern healthcare. #RedefiningMedicalAffairs #PharmaInnovation #AIinHealthcare #DigitalTransformation
To view or add a comment, sign in
-
Medical Affairs & Medical Communications - Connecting the best talent with market leading organizations
I thoroughly enjoyed listening to Samm Zombolo, Sanjeev Welling and Avira Digital discussing the evolution of medical affairs! What are your thoughts on the evolution of medical affairs?
CEO, Avira Digital, Advancing patient care with Integrated Evidence & Medical Affairs Planning Digitization and GenAI
In this week's episode of Redefining Evidence Management, we have Samm Zombolo, Senior Vice President of Medical Affairs and HEOR at EPM Scientific, discussing her unique journey into medical affairs. Samm shares her insights on the transformative impact of digital advancements and AI on the pharmaceutical and biotech industries. Discover how integrating technology is reshaping medical affairs and the importance of adaptability in this fast-evolving field. Join us as Samm explores the future of medical affairs, the integration of strategic development, and the role of patient-centric approaches in modern healthcare. #RedefiningMedicalAffairs #PharmaInnovation #AIinHealthcare #DigitalTransformation
To view or add a comment, sign in
-
So many of you in my network already know Samm Zombolo, so I know this will be of interest! Samm had a great conversation about the current state of medical affairs and where we're going. Give a listen and let us know your thoughts! #medicalaffairs
CEO, Avira Digital, Advancing patient care with Integrated Evidence & Medical Affairs Planning Digitization and GenAI
In this week's episode of Redefining Evidence Management, we have Samm Zombolo, Senior Vice President of Medical Affairs and HEOR at EPM Scientific, discussing her unique journey into medical affairs. Samm shares her insights on the transformative impact of digital advancements and AI on the pharmaceutical and biotech industries. Discover how integrating technology is reshaping medical affairs and the importance of adaptability in this fast-evolving field. Join us as Samm explores the future of medical affairs, the integration of strategic development, and the role of patient-centric approaches in modern healthcare. #RedefiningMedicalAffairs #PharmaInnovation #AIinHealthcare #DigitalTransformation
To view or add a comment, sign in
-
PA Consulting's research shows that 64% of consumers want to share their health data for clinical research. And so, how can pharma and biotech companies harness the power of data to enable better Clinical Trial decisions, enhance patient outcomes and accelerate research? Find out how in the 'A dose of innovation' report. #HealthData
Research report: Understanding the attitudes towards clinical research
paconsulting.smh.re
To view or add a comment, sign in
-
Lets learn how the cutting-edge technologies and innovative approaches that are reshaping the landscape of healthcare marketing. Join us as we delve into the fascinating intersection of data science and pharmaceuticals, paving the way for a brighter and more personalized future in medicine. Read the full article here: https://lnkd.in/gPnPjXP3 #PharmaceuticalMarketing #RealWorldData #HealthcareInnovation
To view or add a comment, sign in
-
Why O4 Research? Four values power our success. Yours, too. At O4 Research, we are open, original, obsessive and on your side. Pharma, Biotech, Consumer Health and Medical device organisations that are trusted by millions of health care professionals, trust us with their reputation. We listen hard then work even harder to perfect the processes that will work best for you and your studies. Find out more on our site: https://www.o4research.com #O4Research #ClinicalResearch #PharmaPartnerships #BiotechInnovation #RealWorldEvidence #ClinicalTrialDesign #DrugDevelopment #FunctionalSupportServices #HealthcareSolutions #MedicalDeviceDevelopment #PatientCareStudies #ResearchAndDevelopment
To view or add a comment, sign in
-
The Power of Scoping Reviews in Medical Affairs Strategic Insights with Comprehensive Evidence Mapping In the fast-paced world of pharmaceuticals, staying ahead of the curve is crucial. Medical Affairs teams are at the heart of ensuring that clinical data is translated into actionable insights. But how do you keep up with the ever-evolving landscape of medical research? The answer lies in Scoping Reviews. At Clinical Insights, we specialize in conducting thorough scoping reviews that provide your Medical Affairs team with a comprehensive understanding of the existing evidence base. Our reviews map out the entire research landscape, helping you identify key trends, knowledge gaps, and opportunities to enhance your product’s clinical positioning. Why choose Clinical Insights? 🔍 Comprehensive Evidence Mapping – We ensure no stone is left unturned. 📊 Actionable Insights – Translate data into strategic decisions. 📈 Stay Competitive – Ensure your strategies are informed by the latest research. https://lnkd.in/dR2nPXJh #MedicalAffairs #Pharma #ScopingReview #ClinicalInsights #EvidenceBasedMedicine
Clinical Insights
clinical-insights.org
To view or add a comment, sign in
-
Global Market Access Assignee | Key Account Manager | MBA | Mckinsey & Company FORWARD Program Alumni| Project Management | Finance Principles | Market Access Strategy |Hospital Sales Management |
🌟 Why Life Science Comapnies use Real World Evidence?🌟 Real-world Evidence 📜is transforming the way we understand patient experiences and outcomes, guiding healthcare decisions for the better. As we delve into patient lifetimes and personal journeys, we gain valuable insights that inform the medical community and decision-makers on what truly works for individuals. 🟢Payers are increasingly recognizing the importance of providing access to innovative drugs, even with high upfront costs, when long-term savings and patient benefits are evident. This shift towards prioritizing patient outcomes is a game-changer in healthcare. 🟢Moreover, by improving the quality of risk-sharing agreements between pharmaceutical companies and payers, we can ensure that access to cutting-edge solutions remains uninterrupted. These agreements, based on real-world outcomes, pave the way for sustainable collaborations that benefit all parties involved. 🟢Also that will support Pharma companies to improve the clinical & economic value of their drugs & medical devices, accelerate the process of regulatory approval & reduce financial burdens, amenable higher quality of care & improve patient’s outcumes . 💊 #HealthcareInnovation #RealWorldData #PatientOutcomes #CollaborationGoals
To view or add a comment, sign in
28,361 followers